Universe · entity
Logos Global Management LP
Institutional manager (13F) · CIK 1792126
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $1.9B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | $195M | 2,000,000 |
| 2 | ERASCA INC | $180M | 11,150,000 |
| 3 | IDEAYA BIOSCIENCES INC | $115M | 3,450,000 |
| 4 | PRAXIS PRECISION MEDICINES I | $92M | 285,000 |
| 5 | CENTESSA PHARMACEUTICALS PLC | $84M | 2,125,000 |
| 6 | TERNS PHARMACEUTICALS INC | $79M | 1,500,000 |
| 7 | ABIVAX SA | $75M | 675,000 |
| 8 | TANGO THERAPEUTICS INC | $63M | 3,000,000 |
| 9 | CYTOKINETICS INC | $58M | 875,000 |
| 10 | OLEMA PHARMACEUTICALS INC | $48M | 3,208,875 |
| 11 | UNITED THERAPEUTICS CORP DEL | $47M | 80,000 |
| 12 | IMMUNOCORE HLDGS PLC | $45M | 1,500,000 |
| 13 | MADRIGAL PHARMACEUTICALS INC | $44M | 85,000 |
| 14 | RHYTHM PHARMACEUTICALS INC | $39M | 450,000 |
| 15 | CG ONCOLOGY INC | $39M | 575,000 |
| 16 | MAZE THERAPEUTICS INC | $37M | 1,235,000 |
| 17 | BIOGEN INC | $37M | 200,000 |
| 18 | DISC MEDICINE INC | $36M | 560,000 |
| 19 | DIANTHUS THERAPEUTICS INC | $34M | 400,000 |
| 20 | OCULAR THERAPEUTIX INC | $33M | 3,850,000 |
| 21 | TYRA BIOSCIENCES INC | $33M | 850,000 |
| 22 | TREVI THERAPEUTICS INC | $29M | 2,400,000 |
| 23 | MOONLAKE IMMUNOTHERAPEUTICS | $28M | 1,500,000 |
| 24 | IMMUNOVANT INC | $27M | 1,075,000 |
| 25 | XENON PHARMACEUTICALS INC | $26M | 450,000 |
| 26 | ARCUS BIOSCIENCES INC | $26M | 1,200,000 |
| 27 | DYNE THERAPEUTICS INC | $25M | 1,400,000 |
| 28 | STRUCTURE THERAPEUTICS INC | $24M | 500,000 |
| 29 | LB PHARMACEUTICALS INC | $23M | 915,000 |
| 30 | ENLIVEN THERAPEUTICS INC | $21M | 540,000 |
| 31 | DESIGN THERAPEUTICS INC | $21M | 1,950,000 |
| 32 | MINERVA NEUROSCIENCES INC | $19M | 3,215,000 |
| 33 | NEWAMSTERDAM PHARMA COMPANY | $19M | 600,000 |
| 34 | MIRUM PHARMACEUTICALS INC | $18M | 200,000 |
| 35 | VAXCYTE INC | $17M | 300,000 |
| 36 | ACADIA PHARMACEUTICALS INC | $17M | 750,000 |
| 37 | COMPASS THERAPEUTICS INC | $17M | 3,150,000 |
| 38 | CELLDEX THERAPEUTICS INC NEW | $14M | 450,000 |
| 39 | JANUX THERAPEUTICS INC | $14M | 1,000,000 |
| 40 | VOR BIOPHARMA INC | $13M | 750,000 |
| 41 | ALKERMES PLC | $12M | 350,000 |
| 42 | ORIC PHARMACEUTICALS INC | $12M | 950,000 |
| 43 | IMMIX BIOPHARMA INC | $11M | 1,225,000 |
| 44 | TENAX THERAPEUTICS INC | $10M | 625,000 |
| 45 | AMYLYX PHARMACEUTICALS INC | $10M | 700,000 |
| 46 | CRESCENT BIOPHARMA INC. | $9M | 482,500 |
| 47 | SOLENO THERAPEUTICS INC | $8M | 250,000 |
| 48 | ARRIVENT BIOPHARMA INC | $8M | 350,000 |
| 49 | RELAY THERAPEUTICS INC | $7M | 750,000 |
| 50 | CORVUS PHARMACEUTICALS INC | $7M | 450,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.